Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review.  Wilson LA, Gandhi P.  JMIR Res Protoc. 2023 May 10;12:e42417. doi: 10.2196/42417. PMID: 37163329; PMCID: P...

P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses.  Ho H, Zhang E.  Front Pharmacol. 2023 May 4;14:1182571. doi: 10.3389/fphar.2023.1182571. PMID: 37214474; PMCID: PMC10192552. htt...

Methadone alters transcriptional programs associated with synapse formation in human cortical organoids.  Dwivedi I, Caldwell AB, Zhou D, Wu W, Subramaniam S, Haddad GG.  Transl Psychiatry. 2023 May 6;13(1):151. doi: 10.1038/s41398-023...

USA. Advisory: Evidence-Based, Whole Person Care of Pregnant People Who Have Opioid Use Disorder This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who tre...

Pain Management After Cesarean Delivery Among Women with Opioid Use Disorder: Results from a Retrospective Pregnancy Cohort in a Rural Region of the Midwest. Riddle J, Botsford JA, Dean S, Coffman C, Robinson CA, Kerver JM.  Womens Health R...

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy.  Tavakoli A, Donovan K, Sweeney H, Uquillas K, Gordon B.  Cureus. 2023 Mar 19;15(3):e36376. doi: 10.7759/cureus.36376. PMID: 37090287; PMCID: PMC10113565. https:/...